No Data
No Data
WHO Approves First Mpox Diagnostic Test for Emergency Use
Fitch Confirms Roche's Rating on Strong Pharmaceutical Business Profile
Redburn Atlantic Lowers Price Target on Roche Holding Genusschein AG, Maintains Buy Recommendation
Kepler Capital Sticks to Its Buy Rating for Roche Holding AG (RHHVF)
Eli Lilly and Co (LLY.US) explores new uses for "miracle weight-loss drug" Zepbound, aiming to reduce the incidence of diabetes and other high-risk populations.
eli lilly and co is exploring new uses for its weight loss drug Zepbound to reduce the incidence of diabetes in high-risk populations, even if they are not overweight.
Lonza Announced Acquisition on March 20
No Data
No Data